Saturation index and fraction of inspired oxygen as a predictor in COVID-19
DOI:
https://doi.org/10.5281/zenodo.8319752Keywords:
Oxygen, Hypoxia, Mortality, COVID-19Abstract
Background: Coronavirus disease leads to silent hypoxia, ARDS, and organ failure. The saturation and fraction of inspired oxygen have been related to the degree of lung damage, can be considered as a monitoring tool for lung function during hospitalization and a predictor of mortality in patients with pneumonia by COVID-19.
Objective: To evaluate the usefulness of the oxygen saturation index and fraction of inspired oxygen as a predictor of mortality in patients with COVID-19 pneumonia.
Material and methods: A retrospective, longitudinal, analytical study. Files of eligible patients with a diagnosis of SARSCoV-2 pneumonia were admitted to HGR No.2, complete file, recording of oxygen saturation and inspired fraction of oxygen, were included. Patients dependent on supplemental oxygen, who did not require supplemental oxygen during their hospitalization, incomplete records, patients who have died from non-pulmonary causes, were excluded.
Results: A sample of 175 records of patients diagnosed with SARS-CoV-2 pneumonia was obtained. A logistic regression model was performed including: age over 60 years, mellitus diabetes, systemic arterial hypertension, SAFI index, and endotracheal intubation.
Conclusion: The SpO2/Fio2 index can be used for continuous monitoring of lung function in patients with COVID-19 pneumonia, in an accessible, easy and economical way. A relationship with mortality was obtained in patients with SpO2/FiO2 less than 310 associated with other factors.
Downloads
References
Stratton CW, Tang YW, Lu H. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Journal of Medical Virology. 2021;93(3):1320-1342. DOI: 10.1002/jmv.26610.
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). Journal of the American medical association. 2020. DOI: 10.1001/ jama.2020.12839.
Gautret P, Million M, Jarrot PA, Camoin-Jau L, Colson P, et al. Natural history of COVID-19 and therapeutic options. Expert Review of Clinical Immunology. 2020; 16 (12): 1159-1184. DOI: 10.1080/1744666X.2021.1847640.
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. Journal of American Medicine Association. 2020;323(16): 1574. DOI: 10.1001/jama.2020.5394.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine. 2020;382:727-33. DOI: 10.1056/ NEJMoa2001017.
Beasley R, Chien J, Douglas J, Eastlake L, Farah C, King G, et al. Target oxygen saturation range: 92-96% Versus 94-98%. Asian Pacific Society of Respirology. 2017;22(1):200-202. DOI: 10.1111/resp.12879.
Dos Santos WG. Natural history of COVID-19 and current knowledge on treatment therapeutic options. Biomedicine & Pharmacotherapy. 2020(129):110493. DOI: 10.1016/j. biopha.2020.110493.
Rahman A, Tabassum T, Araf Y, Nahid A, Ullah A, Hosen M. Silent hypoxia in COVID-19: pathomechanism and possible management strategy. Molecular Biology Reports. 2021;48 (4):3863-3869. DOI: 10.1007/s11033-021-06358-1.
Bickler PE, Feiner JR, Lipnick MS, McKleroy W. CliniCal Focus Review “Silent” Presentation of Hypoxemia and Cardiorespiratory Compensation in COVID-19. Anesthesiology. 2021;134:262-271. DOI: 10.1097/ALN.0000000000003578.
Rodriguez A, Cardona J, Gutiérrez E, Villamizar R, Holguin Y, Escalera J. Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Medicine and Infectious Diseases. 2020;34:101623. DOI: 10.1016/j.tmaid.2020.101623.
Jubran A. Pulse oximetry. Critical Care 2016;19(1):272. DOI: 10.1186/s13054-015-0984-8.
Giamerellos E, Netea M, Rovina N, Koulouris N, Gogos C, Koutoukou T. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020; 10;27(6):992-1000. DOI: 10.1016/j.chom.2020.04.009.
Couzin F. The mystery of the pandemic’s ‘happy hypoxia’. Science. 2020;368(6490):455–456. DOI: 10.1126/science. 368.6490.455.
Rauniyar N, Pujari S, Shrestha P. Study of oxygen saturation by pulse oximetry and arterial blood gas in ICU patients: A descriptive cross-sectional study. Journal of the Nepal Medical Association. 2020;58(230):789-793. DOI: 10.31729/ jnma.5536.
Grupo de Trabajo Mexicano COVID-19/COMMEC. Guía COVID-19 para la atención del paciente crítico con infección por SARS-CoV-2 Colegio Mexicano de Medicina Crítica. Medicina Critica. 2020;34(1):7-42. DOI:10.35366/93279.
Rice T, Wheeler A, Bernard G, Hayden D, Schoenfeld D, Ware L. Comparison of the SpO2/FIO2 ratio and the PaO 2/FIO2 ratio in patients with acute lung injury or ARDS. Chest. 2007; 132(2):410-417. DOI: 10.1378/chest.07-0617.
Serrano A, Trillo E, García L, del Rio A, Molina F, Velilla S. Pulse oximetry: Role in the COVID-19 patient at home. Medicina de familia SEMERGEN. 2021;48(1):70-77. DOI: 10.1016/j.semerg.2021.03.004.
Luks A, Swenson E. Pulse oximetry for monitoring patients with COVID-19 at home potential pitfalls and practical guidance. Annals of the American Thoracic Society 2020;17(9):1040- 1046. DOI: 10.1513/AnnalsATS.202005-418FR.
Festic E, Bansal V, Kor D, Gajic O. SpO2/FiO2 ratio on hospital admission is an indicator of early acute respiratory distress syndrome development among patients at risk. Journal of Intensive Care Medicine. 2020;30(4):209-16. DOI: 10.1177/0885066613516411.
Roozeman J, Mazzinari G, Neto A, Hollmann M, Paulus F, Schultz M, Pisani L. Prognostication using SPO2/FIO2 in invasively ventilated ICU patients with ARDS due to COVID 19 – Insights from the PRoVENT-COVID study. Journal of critical care. 2020;68:31-37. DOI: 10.1016/j.jcrc.2021.11.009.
Choi K, Hong H, Kim E. The association between mortality and the oxygen saturation and fraction of inhaled oxygen in patients requiring oxygen therapy due to COVID-19– Associated pneumonia. Tuberculosis and Respiratory Diseases. 2021;84(2):125-133. DOI: 10.4046/trd.2020.0126.
Wang C, Wei L, Shu K, Chih L, Chien C. The Value of Oxygenation Saturation Index in Predicting the Outcomes of Patients with Acute Respiratory Distress Syndrom. Journal of Clinical Medicine. 2018;7(8):205. DOI: 10.3390/jcm7080205.
Lu X, Jiang L, Chen T, Wang Y, Zhang B, Hong Y, et al. Continuously available ratio of SpO2/FiO2serves as a noninvasive prognostic marker for intensive care patients with COVID-19. Respiratory Research. 2020;21(1):194. DOI: 10.1186/ s12931-020-01455-4.
Rauniyar N, Pujari S, Shrestha P. Study of oxygen saturation by pulse oximetry and arterial blood gas in ICU patients: A descriptive cross sectional study. Journal Nepal Medicine Association. 2020;58(230):789-793. DOI: 10.31729/jnma.5536.
Xie J, Covassin N, Fan Z, Singh P, Gao K, Li G, Somers V. Association between hypoxemia and mortality in patients with COVID 19. Mayo clinic. 2020;(6):1138-1147. DOI: 10.1016/j. mayocp.2020.04.006.
Wick K, Matthay M, Ware L. Pulse oximetry for the diagnosis and management of acute respiratory distress syndrome. Lancet Respiratory Medicine. 2022;10(11);1086-1098. DOI: 10.1016/S2213-2600.
Catoire P, Tellier E, de la Riviere C, Beauvieux M, Valdenaire G, Galinski M, et al. Assessment of the SpO2/FiO2 ratio as a tool for hypoxemia screening in the emergency department. American Journal Emergency Medicine. 2021;44:116-120. DOI: 10.1016/j.ajem.2021.01.092.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Revista Médica del Instituto Mexicano del Seguro Social
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.
